Huma Therapeutics, a leading global digital health company, has announced it will use Google Cloud’s generative AI (GenAI) to enhance Huma’s regulated disease management platform. Huma is also exploring the use of Google’s GenAI tools, including Med-PaLM 2, a large language model specialised for the medical domain, to support healthcare professionals (HCPs) with better insights to optimise care delivery.
Huma’s technology platform captures a range of vital signs, biomarkers and patient-reported data that are displayed on an HCP dashboard. This allows HCPs to care for many more patients than they would be able to in person, helping to alleviate workforce pressures and expand access to healthcare. There are additional, significant efficiencies to be gained by reducing administrative tasks that take away valuable time from delivering patient-centric care and GenAI will be used to automate the generation of clinical summary reports from incoming data and surface relevant information for review in order to improve the documentation and triaging processes.
Aashima Gupta, Global Director of Healthcare Strategy and Solutions, Google Cloud, said: “In a world where healthcare professionals are constantly striving to provide the best care for their patients, GenAI can be a valuable ally to lighten the load. It is not about just reducing cognitive burden; but also enhancing the personalisation of care.”
Click below to share this article